Schedule 13G ownership disclosure

Kura Oncology Inc

Security class unavailable · CUSIP: 50127T109

Event date: 2015-03-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-15-000217
Form type
SC 13G
Filer
ARCH Venture Fund VIII, L.P.
CIK
CIK 1605598
Filed
Mar 13, 2015
Reporting period
Mar 06, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub